Published in Postgrad Med on September 01, 2001
Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran. PLoS One (2010) 0.90
A survey of kidney disease and risk-factor information on the World Wide Web. MedGenMed (2004) 0.84
Changing trends in the referral patterns of pediatric nephrology patients. Pediatr Nephrol (2005) 0.82
The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK. BMJ Open (2013) 0.75
Reverse iontophoresis of urea in health and chronic kidney disease: a potential diagnostic and monitoring tool? Eur J Clin Invest (2012) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med (1994) 11.65
Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem (1992) 8.84
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Transmission of hepatitis C virus by organ transplantation. N Engl J Med (1991) 5.17
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol (2000) 3.27
The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med (1996) 3.15
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol (2001) 3.14
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Mortality and duration of hemodialysis treatment. JAMA (1991) 2.94
Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int (2006) 2.85
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med (1992) 2.78
Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med (1997) 2.78
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int (2000) 2.72
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2001) 2.69
Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int (2008) 2.41
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis (1999) 2.38
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int (1998) 2.14
Occult intracranial aneurysms in polycystic kidney disease. When is cerebral arteriography indicated? N Engl J Med (1983) 2.12
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis (2000) 2.05
Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int (2001) 1.94
Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens (2001) 1.91
Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial. Ann Intern Med (2001) 1.86
The glomerular mesangium. Kidney Int (1980) 1.83
Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 1.79
Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial (2001) 1.79
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int (2001) 1.77
The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation (1995) 1.67
Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis. Yale J Biol Med (1967) 1.67
US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis (2000) 1.65
Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int (2008) 1.64
Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol (2000) 1.62
Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials (2000) 1.60
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol (1987) 1.57
Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med (1993) 1.54
A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet (1995) 1.54
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53
The prophylactic value of propranolol in angina pectoris. Am J Cardiol (1966) 1.51
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients. Ann Intern Med (1994) 1.44
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int (1991) 1.42
A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine (2001) 1.41
Isothermic hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.39
Predictors of GBV-C infection among patients referred for renal transplantation. Kidney Int (1998) 1.39
Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int (2001) 1.38
Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids. J Clin Microbiol (1984) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis (1983) 1.35
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Clin Pharmacol Ther (1985) 1.34
Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet (1996) 1.34
Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol (2002) 1.33
Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int (1984) 1.29
Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int Suppl (1997) 1.28
Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int (1999) 1.23
The effects of heatstroke on the function and structure of the kidney. Q J Med (1967) 1.22
Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int (1990) 1.21
Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int (1997) 1.21
Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med (1981) 1.21
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension (1992) 1.20
Sum of segmental bioimpedance analysis during ultrafiltration and hemodialysis reduces sensitivity to changes in body position. Kidney Int (1999) 1.19
Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis (1987) 1.19
Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis (1999) 1.18
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int (2001) 1.18
The possible role of hemoconcentration in the etiology of myocardial infarction. Am Heart J (1967) 1.17
Renal parenchymal disease: sonographic-histologic correlation. Radiology (1982) 1.17
Placement of an internal jugular dialysis catheter into the superior intercostal vein. Nephrol Dial Transplant (1999) 1.16
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16
Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis (2001) 1.14
Survival and rehabilitation of patients on home hemodialysis. Five years' experience. Ann Intern Med (1973) 1.13
Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res (1988) 1.13
The kidney and homocysteine metabolism. J Am Soc Nephrol (2001) 1.12
Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med (1986) 1.10
Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int (2006) 1.10
The 3rd International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Int J Artif Organs (2005) 1.09
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int (1988) 1.09
Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest (1987) 1.09
Dietary protein and renal function. J Am Soc Nephrol (1993) 1.09
Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis (1986) 1.08
The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int (2000) 1.07
Use of focus groups to identify concerns about dialysis. Choice Study. Med Decis Making (1999) 1.06
Immunoglobulin and dextran losses during peritoneal dialysis. Arch Intern Med (1974) 1.06
Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.06
Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis (2001) 1.05
Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int (2000) 1.05
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am J Pathol (1986) 1.04
Psychosocial factors affecting adherence to medical regiments in a group of hemodialysis patients. Med Care (1982) 1.03
Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs (1977) 1.03
Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis (1994) 1.03
Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther (2009) 1.03
Continuous peritoneal dialysis for chronic renal failure. Medicine (Baltimore) (1982) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Renal energy metabolism and sodium reabsorption. Annu Rev Med (1973) 1.02